Related references
Note: Only part of the references are listed.Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention
Min Tian et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up
Mathijs C. Bodde et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Dyslipidemia in Patients with a Cardiovascular Risk and Disease at the University Teaching Hospital of Yaounde, Cameroon
Vicky Jocelyne Ama Moor et al.
INTERNATIONAL JOURNAL OF VASCULAR MEDICINE (2017)
The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity
Jan Boren et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography
Yongyan Song et al.
LIPIDS IN HEALTH AND DISEASE (2015)
Acute coronary syndromes in young patients: Presentation, treatment and outcome
Andreas W. Schoenenberger et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Effect of torcetrapib on the progression of coronary atherosclerosis
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study
C Meisinger et al.
EUROPEAN HEART JOURNAL (2005)
Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy
G Walldius et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men
PJ Talmud et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study
G Walldius et al.
LANCET (2001)
Share Paper
